Long-term outcome after totally thoracoscopic ablation for atrial fibrillation

Autor: Sander G. Molhoek, Guillaume S.C. Geuzebroek, Bart P. van Putte, Lara M. Vos, Mohamed Bentala
Přispěvatelé: Cardiothoracic Surgery, Graduate School, ACS - Atherosclerosis & ischemic syndromes
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Reoperation
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Action Potentials
Rhythm control
030204 cardiovascular system & hematology
ablation
rhythm
Disease-Free Survival
03 medical and health sciences
0302 clinical medicine
Primary outcome
Postoperative Complications
Refractory
Heart Rate
Recurrence
Risk Factors
Physiology (medical)
Internal medicine
medicine
Humans
Atrial Appendage
atrial fibrillation
thoracoscopic
030212 general & internal medicine
cardiovascular diseases
Stroke
Aged
long-term
business.industry
Thoracoscopy
Other Research Radboud Institute for Health Sciences [Radboudumc 0]
Atrial fibrillation
Mean age
Middle Aged
Ablation
medicine.disease
stroke
Catheter
Pulmonary Veins
Cardiology
Catheter Ablation
Female
Cardiology and Cardiovascular Medicine
business
Zdroj: Journal of cardiovascular electrophysiology, 31(1), 40-45. Wiley-Blackwell
Journal of Cardiovascular Electrophysiology, 31, 40-45
Journal of Cardiovascular Electrophysiology, 31, 1, pp. 40-45
ISSN: 1045-3873
Popis: Contains fulltext : 218103.pdf (Publisher’s version ) (Closed access) INTRODUCTION: Totally thoracoscopic ablation for symptomatic atrial fibrillation (AF) refractory to drug or catheter based therapy is indicated as a Class 2A recommendation according to latest guidelines. Evidence for long-term rhythm control and stroke reduction is limited. The aim of this study was to report on long-term outcome after totally thoracoscopic ablation. METHODS AND RESULTS: In total 82 consecutive patients were included that underwent totally thoracoscopic ablation including left appendage closure (2012-2013). The primary outcome was freedom from atrial arrhythmia recurrence. Secondary outcomes were survival, freedom from cerebrovascular events, freedom from reablation and definite pacemaker implantation. The mean age was 59.9 +/- 8.6 years and 71% were male. The mean CHA2 DS2 -VASc score was 1.2 +/- 1.0. The overall freedom from atrial arrhythmia was 60% after a mean follow up of 4.0 +/- 0.6 years. Freedom from cerebrovascular events was 98.8% after mean follow-up of 4.4 +/- 0.3 years and overall survival was 98.8%, with one noncardiac related death. The observed rate of ischemic stroke, hemorrhagic stroke or transient ischemic attack was 0.3 per 100 patient-years. CONCLUSIONS: Totally thoracoscopic ablation is an effective sustainable rhythm control therapy for AF with a reasonable recurrence rate and low stroke rate when performed in dedicated AF centers.
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje